Using Scrambler Therapy to treat pain after a stroke
Scrambler Therapy for Post-Stroke Pain
This study is testing if Scrambler Therapy can help people who have pain after a stroke feel better compared to regular pain medications.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Johns Hopkins University Academic / other |
| Locations | 1 site (Baltimore, Maryland) |
| Trial ID | NCT05563038 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of Scrambler Therapy compared to traditional pharmacologic treatments for patients experiencing post-stroke pain. Participants will be enrolled if they are at least one month post-stroke and have pain related to their stroke location. They will choose their preferred treatment method and will be monitored for pain relief over the course of a year using standardized pain scores. The study will compare the maximum pain relief and duration of relief achieved between the two treatment groups.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 who have experienced an ischemic or hemorrhagic stroke and have pain in areas affected by their stroke.
Not a fit: Patients with transient ischemic attacks, no evidence of stroke on MRI, or those with certain medical devices or conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide an alternative pain management option for patients suffering from post-stroke pain.
How similar studies have performed: While Scrambler Therapy is a novel approach, similar studies have shown promising results in pain management, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men and women over the age of 18 with ischemic or hemorrhagic stroke seen on imaging and a positive finding for pain in the area(s) affected by their stroke location will be included. * The patients must be at least one month post-stroke but can otherwise enroll at any point. Exclusion Criteria: * Patients with TIA * Patients with no evidence of stroke on MRI * Patients with implantable devices such as pacemakers, defibrillators, spinal cord stimulators * Patients with history of myocardial infarction in the past 6 months * Patients with uncontrolled epilepsy * Patients with symptomatic brain metastases
Where this trial is running
Baltimore, Maryland
- Johns Hopkins Bayview Hospital — Baltimore, Maryland, United States (Recruiting)
Study contacts
- Principal investigator: Dawn Merbach, MNP — Johns Hopkins University
- Study coordinator: Dawn Merbach, MNP
- Email: dmerbac1@jhmi.edu
- Phone: 4105508065
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.